国际麻醉学与复苏杂志   2014, Issue (12): 5-5
    
新型口服抗凝药在围术期的合理应用
王建, 王飞1()
1.济南军区总医院麻醉科
Managing new oral anticoagulants in the perioperative period
 全文:
摘要:

背景 抗凝是重要的临床问题,目前传统抗凝药正逐渐被新型口服抗凝药(new oral anticoagulants, NOACs)取代。NOACs的优势包括可口服、起效迅速、消除快、抗凝效果具有可预测性、无需常规监测等。 目的 综述NOACs在围术期应用的最新研究进展。 内容 概述NOACs的药理学特点及临床应用,探讨其在围术期的合理应用。 趋向 NOACs应根据患者肾功能和具体手术操作在术前尽量停用适当的时间。

关键词: 新型口服抗凝药; 围术期; 血栓
Abstract:

Background Anticoagulation is an important clinical issue. At present, the new oral anticoagulants (NOACs) are increasingly replacing traditional anticoagulants in clinical practice. Advantages of these new agents include their rapid onset and elimination, predictable anticoagulant effect and no need for routine monitoring. Objective To report the recent progress in NOACs applied in the perioperative period. Content To summarize the current literature on NOACs' pharmacology and clinical application, especially in the period of operation. Trend If possible, the NOACs should be suspended preoperatively for a certain time based on patient's renal function and operative procedure.

Key words: New oral anticoagulants; Perioperative period; Thrombosis